Cognition Therapeutics, Inc. (CGTX) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Cognition Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -4.18x | -0.82x | -2.15x | 80.43x | -11.99x | -27.81x |
| P/B Ratio | 2.87x | 1.49x | 2.27x | 1.51x | 2.74x | -4.11x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 3.45x | 2.65x | 3.37x | 6.11x | 7.50x | 2.13x |
| Quick Ratio | 3.45x | 2.65x | 3.37x | 6.11x | 7.50x | 2.13x |
| Leverage | ||||||
| Debt/Equity | 0.02x | 0.04x | 0.05x | 0.04x | 0.00x | -0.19x |
YoY = year-over-year change. Source: FMP..